版本:
中国

BRIEF-Myriad Genetics launches the endopredict test in U.S for patients with breast cancer

March 13 Myriad Genetics Inc

* Myriad Genetics launches the endopredict test in the United States for patients with breast cancer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐